Calendario de promoción Ascendis Pharma A/S
Horario avanzado
gráfico sencillo
Acerca de la empresa Ascendis Pharma A/S
Ascendis Pharma A / S, биофармацевтическая компания, разрабатывает терапевтические препараты для неудовлетворенных медицинских потребностей. Компания разрабатывает гормон роста TransCon, который завершил III фазу клинических испытаний дефицита гормона роста. Он также разрабатывает паратиреоидный гормон TransCon для лечения гипопаратиреоза взрослых; и TransCon CNP для ахондроплазии. más detalles| IPO date | 2015-01-28 |
|---|---|
| ISIN | US04351P1012 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | eur |
| Сайт | https://ascendispharma.com |
| Цена ао | 134.38 |
| Cambio de precio por día: | +0.5569% (127.49) |
|---|---|
| Cambio de precio por semana.: | +0.0546% (128.13) |
| Cambio de precio por mes: | -7.63% (138.79) |
| Cambio de precio en 3 meses.: | -1.63% (130.32) |
| Cambio de precio en seis meses: | -3.97% (133.5) |
| Cambio de precio por año: | -4.61% (134.39) |
| Cambio de precio en 3 años.: | +10.67% (115.84) |
| Cambio de precio en 5 años.: | -6.66% (137.35) |
| Cambio de precio en 10 años.: | 0% (128.2) |
| Cambio de precio desde principios de año.: | -3.19% (132.42) |
|
|
Subestimación
|
Eficiencia
|
|||||||||||||||||||||||||||||||||||||
Dividendos
|
Deber
|
Impulso de crecimiento
|
|||||||||||||||||||||||||||||||||||||
| Instituciones | Volumen | Compartir, % |
|---|---|---|
| Artisan Partners Limited Partnership | 6 | 9.74 |
| FMR, LLC | 5 | 8.48 |
| Westfield Capital Management Co LP | 4 | 7 |
| Avoro Capital Advisors LLC | 4 | 6.81 |
| Janus Henderson Group PLC | 4 | 6.47 |
| Wellington Management Group, LLP | 3 | 4.72 |
| T. Rowe Price Investment Management, Inc. | 3 | 4.41 |
| Capital International Investors | 2 | 3.76 |
| Franklin Resources, Inc. | 2 | 3.4 |
| Price (T.Rowe) Associates Inc | 2 | 3.06 |
| ETF | Compartir, % | Rentabilidad del año, % | Dividendos, % |
|---|---|---|---|
| Harbor Health Care ETF | 15.049 | 19.98 | 1.85 |
| Harbor Disruptive Innovation ETF | 1.94674 | 29.05 | 0.39896 |
| Virtus LifeSci Biotech Products ETF | 1.73873 | 36.79 | 0.13953 |
| American Century Focused Dynamic Growth ETF | 1.00544 | 51.92 | 0.16246 |
| Invesco Nasdaq Biotechnology ETF | 0.8571 | 28.58 | 0.8565 |
| Simplify Health Care ETF | 0.85284 | 27.81 | 1.00373 |
| Future Tech ETF | 0.85005 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.85005 | 618.5 | 0.8416 |
| ProShares UltraShort Nasdaq Biotechnology | 0.77 | -40.36 | 1.76 |
| Northern Lights Fund Trust IV | 0.69803 | 42.1 | 0.49246 |
| ProShares Ultra Nasdaq Biotechnology | 0.57302 | 51.7 | 0.85651 |
| Putnam Sustainable Future ETF | 0.48877 | 32.87 | 0.70689 |
| First Trust Nasdaq BuyWrite Income ETF | 0.19858 | 7.27 | 0.92977 |
SPDR Portfolio Developed World ex-US ETF
|
0.02162 | 5.29 | 3.28401 |
| PIMCO RAFI Dynamic Multi-Factor International Equity ETF | 0.01902 | 12.12 | 3.49094 |
| Fidelity Blue Chip Growth ETF | 0.01204 | 39.34 | 0.54012 |
| Supervisor | Título profesional | Pago | año de nacimiento |
|---|---|---|---|
| Mr. Jan Moller Mikkelsen | President, CEO, Member of Executive Board & Executive Director | N/A | 1960 (65 años) |
| Mr. Michael Wolff Jensen L.L.M. | Executive VP, Chief Legal Officer & Member of the Executive Board | N/A | 1971 (54 año) |
| Mr. Scott T. Smith | CFO, Executive VP & Member of Executive Board | N/A | 1974 (51 año) |
| Ms. Lotte Sonderbjerg | Executive VP, Chief Administrative Officer & Member of the Executive Board | N/A | 1961 (64 año) |
| Mr. Flemming Steen Jensen | Executive Vice President of Product Supply & Quality | N/A | 1961 (64 año) |
| Mr. Timothy J. Lee | Senior Director of Investor Relations | N/A | |
| Dr. Kennett Sprogoe Ph.D. | Executive VP and Head of Research & Product Development | N/A | 1979 (46 años) |
| Mr. Mads Bodenhoff | Senior VP of Finance & Principal Accounting Officer | N/A | |
| Dr. Stina Singel M.D., Ph.D. | Executive VP & Head of Clinical Development for Oncology | N/A | 1974 (51 año) |
| Mr. Joseph Kelly | Head of U.S. Commercial of Endocrinology | N/A | 1969 (56 años) |
DIRECCIÓN: Denmark, Hellerup, Tuborg Boulevard 12 - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://ascendispharma.com
Sitio web: https://ascendispharma.com
